Get the App

Download on the

App Store

Get it on

Google play

Get the App

Download on the

App Store

Get it on

Google play

Get the App

Download on the

App Store

Get it on

Google play

Back

NEET PG GIT Pharmacology Glossary 2026: PPIs, Antiemetics, H. pylori Regimens, Prokinetics and Antacids

Master GIT pharmacology for NEET PG 2026 with high-yield drug mechanisms, side effects, clinical applications, and MCQ mnemonics. Complete guide to PPIs, antiemetics, H. pylori regimens, prokinetics and antacids.

Cover: NEET PG GIT Pharmacology Glossary 2026: PPIs, Antiemetics, H. pylori Regimens, Prokinetics and Antacids

NEET PG GIT Pharmacology Glossary 2026: PPIs, Antiemetics, H. pylori Regimens, Prokinetics and Antacids

You're 3 months into NEET PG prep and GIT pharmacology feels like memorizing a phone book. PPIs, H2 blockers, prokinetics, antiemetics - 200+ drugs with overlapping mechanisms and side effects that blur together during late-night study sessions. Here's the truth: NEET PG tests pattern recognition, not rote memorization.

This glossary breaks down every high-yield GIT drug you'll see in NEET PG 2026 and INICET. We'll cover mechanisms that actually matter for MCQs, side effects they love to test, and the mnemonics that stick when you're under exam pressure. No fluff, just the drugs and concepts that show up in 80% of GIT pharmacology questions.

Proton Pump Inhibitors (PPIs): The Acid Suppression Masters

PPIs irreversibly inhibit H+/K+-ATPase pumps in parietal cells, achieving 90-95% acid suppression. They need acid activation to work, which is why they're taken 30 minutes before meals when acid production peaks.

High-Yield PPI Facts

Mechanism: Irreversible inhibition of proton pumps → 24-72 hour effect even after single dose Duration: Acid suppression lasts until new pumps are synthesized (3-5 days for complete recovery) First-line for: GERD, peptic ulcers, H. pylori eradication, Zollinger-Ellison syndrome

Drug

Dose

Key Points

NEET PG Favorites

Omeprazole

20-40 mg OD

First PPI, CYP2C19 metabolism

Drug interactions with warfarin, clopidogrel

Esomeprazole

20-40 mg OD

S-isomer of omeprazole, better bioavailability

IV formulation available

Pantoprazole

40 mg OD

Least drug interactions

Safest in cardiac patients

Lansoprazole

15-30 mg OD

Fastest onset

First-choice in elderly

Rabeprazole

20 mg OD

Minimal CYP metabolism

Least affected by genetic polymorphisms

PPI Side Effects (MCQ Favorites)

Chronic use complications:

  • Hypomagnesemia → seizures, arrhythmias (test every 3 months on long-term therapy)

  • Vitamin B12 deficiency → megaloblastic anemia after 2+ years

  • Increased fracture risk → hip, spine, wrist (especially >65 years)

  • C. difficile infections → altered gut microbiome

  • Renal injury → acute interstitial nephritis (rare but serious)

Mnemonic: "PPIs HARM"Pneumonia risk, Poor B12 absorption, Increased fractures, Hypomagnesemia, Acute nephritis, Rebound hyperacidity, Microbiome changes

When memorizing drug interactions, Oncourse's Synapses mnemonic engine automatically generates visual memory hooks for complex pharmacology associations - like linking omeprazole's CYP2C19 interaction to warfarin bleeding risks through memorable story chains.

PPI Clinical Pearls

Rebound hyperacidity: Occurs after stopping long-term PPIs due to gastrin-induced parietal cell hyperplasia. Taper gradually over 4-8 weeks. Drug interactions: Omeprazole inhibits CYP2C19 → reduces clopidogrel effectiveness and increases warfarin levels. Pantoprazole has minimal interactions. H. pylori resistance: PPI resistance doesn't exist - bacterial resistance is to antibiotics, not acid suppression.

H2 Receptor Antagonists: The Backup Acid Blockers

H2 blockers competitively inhibit histamine at parietal cell H2 receptors, achieving 70-80% acid suppression with 6-12 hour duration.

H2 Blocker Comparison

Drug

Potency

Key Feature

Main Side Effect

Cimetidine

1x

First H2 blocker, most interactions

Gynecomastia, anti-androgenic effects

Ranitidine

4x

Most prescribed (withdrawn 2019)

NDMA contamination issue

Famotidine

20x

Most potent, least interactions

Safest profile

Nizatidine

4x

No hepatic metabolism

Minimal drug interactions

Mnemonic: "CRFN" for potency → Cimetidine (1x), Ranitidine (4x), Famotidine (20x), Nizatidine (4x)

H2 Blocker Clinical Points

Tolerance: Develops within 2-4 weeks due to receptor upregulation. Not seen with PPIs. Cimetidine specifics: Inhibits multiple CYP enzymes → increases levels of warfarin, phenytoin, theophylline. Anti-androgenic effects → gynecomastia in men, galactorrhea in women. Current status: Ranitidine withdrawn globally due to NDMA (carcinogenic) contamination. Famotidine is now first-choice H2 blocker.

Antacids: The Immediate Relief Agents

Antacids directly neutralize gastric acid, providing rapid symptom relief in 2-5 minutes but short duration (30-60 minutes).

Antacid Categories

Aluminum-based:

  • Aluminum hydroxide: Constipating, binds phosphate → hypophosphatemia

  • Best for: Hyperphosphatemia in CKD patients

  • Side effects: Constipation, phosphate depletion, CNS toxicity in renal failure

Magnesium-based:

  • Magnesium hydroxide: Laxative effect, rapid neutralization

  • Best for: Patients with constipation

  • Side effects: Diarrhea, hypermagnesemia in renal failure

Calcium-based:

  • Calcium carbonate: Most potent neutralizer, calcium source

  • Best for: Osteoporosis prevention with acid suppression

  • Side effects: Rebound hyperacidity, milk-alkali syndrome, constipation

Sodium bicarbonate:

  • Immediate action: Fastest onset, shortest duration

  • Best for: Acute heartburn relief

  • Side effects: Sodium overload, metabolic alkalosis, rebound hyperacidity

Mnemonic: "AMCS" for antacid effects → Aluminum Constipates, Magnesium Makes loose stools, Calcium Causes rebound, Sodium Supplies alkalosis

Antacid Drug Interactions

Absorption interference: Separate administration by 2 hours from:

  • Iron supplements (reduced absorption)

  • Tetracyclines (chelation)

  • Fluoroquinolones (chelation)

  • Ketoconazole (needs acid for absorption)

Antiemetics: The Nausea Controllers

Antiemetics target different pathways in the vomiting reflex. NEET PG tests mechanism-based drug selection for specific causes of nausea.

Antiemetic Mechanisms and Drugs

Antiemetic drug mechanisms and vomiting reflex pathways for NEET PG pharmacology

5-HT3 Antagonists (Setrons):

  • Ondansetron: First-line for chemotherapy-induced nausea, post-op nausea

  • Mechanism: Block serotonin receptors in CTZ and vagal afferents

  • Dose: 4-8 mg IV/PO, can repeat every 4-6 hours

  • Side effects: Headache, constipation, QT prolongation

  • NEET PG favorite: Drug of choice for cisplatin-induced emesis

Dopamine Antagonists:

  • Metoclopramide: D2 receptor blocker, also prokinetic

  • Mechanism: Blocks D2 receptors in CTZ + increases gastric motility

  • Dose: 10 mg TDS before meals

  • Side effects: Extrapyramidal symptoms, tardive dyskinesia, prolactin elevation

  • Contraindications: GI obstruction, pheochromocytoma

Antihistamines:

  • Promethazine: H1 blocker with strong sedative effects

  • Mechanism: Blocks histamine and muscarinic receptors

  • Best for: Motion sickness, pregnancy-related nausea

  • Side effects: Sedation, dry mouth, blurred vision

Anticholinergics:

  • Scopolamine: Muscarinic antagonist, transdermal patch

  • Mechanism: Blocks muscarinic receptors in vestibular system

  • Best for: Motion sickness prevention

  • Duration: 72-hour patch application

Antiemetic Drug Selection by Cause

Cause of Nausea

First-line Drug

Alternative

Mechanism

Chemotherapy

Ondansetron

Metoclopramide

5-HT3 blockade

Post-operative

Ondansetron

Promethazine

CTZ inhibition

Motion sickness

Scopolamine

Promethazine

Vestibular blockade

Pregnancy

Promethazine

Metoclopramide

H1 antagonism

Gastroparesis

Metoclopramide

Domperidone

Prokinetic + D2 block

Mnemonic: "STAMP" for antiemetic selection → Setrons for Surgery/chemo, Transdermal scopolamine for Travel, Antihistamines for All-day sickness, Metoclopramide for Motility issues, Promethazine for Pregnancy

H. pylori Eradication Regimens

H. pylori resistance patterns change annually, making current regimens crucial for NEET PG 2026. Standard triple therapy success rates have dropped to 70-80% due to clarithromycin resistance.

First-line Regimens (2026 Guidelines)

Standard Triple Therapy (when clarithromycin resistance <15%):

  • PPI (omeprazole 20 mg BD) + Clarithromycin 500 mg BD + Amoxicillin 1 g BD

  • Duration: 14 days

  • Success rate: 70-80% (declining due to resistance)

Quadruple Therapy (first-line in high-resistance areas):

  • Bismuth 525 mg QID + Metronidazole 250 mg QID + Tetracycline 500 mg QID + PPI BD

  • Duration: 10-14 days

  • Success rate: 85-90%

Sequential Therapy:

  • Days 1-5: PPI + Amoxicillin 1 g BD

  • Days 6-10: PPI + Clarithromycin 500 mg BD + Metronidazole 400 mg BD

  • Success rate: 80-85%

Second-line Regimens

After first-line failure:

  • Levofloxacin-based: PPI + Levofloxacin 500 mg OD + Amoxicillin 1 g BD (10 days)

  • Rifabutin-based: PPI + Rifabutin 300 mg OD + Amoxicillin 1 g BD (10 days)


Mnemonic: "PAC MAN" for standard triple → PPI + Amoxicillin + Clarithromycin eats MANy pylori bacteria


H. pylori Resistance Patterns (India 2026)

  • Clarithromycin: 25-30% (increasing annually)

  • Metronidazole: 70-80% (varies by region)

  • Amoxicillin: <5% (rare)

  • Tetracycline: <5% (rare)

  • Levofloxacin: 15-20% (emerging)

When tackling complex H. pylori regimens, Rezzy AI can instantly explain why certain combinations work better in different resistance scenarios - like why bismuth quadruple therapy outperforms triple therapy when clarithromycin resistance exceeds 15%.

Prokinetic Agents: The Motility Enhancers

Prokinetics increase GI motility by enhancing cholinergic neurotransmission or blocking dopamine receptors that inhibit motility.

Major Prokinetic Drugs

Metoclopramide:

  • Mechanism: D2 antagonist + 5-HT4 agonist → increased ACh release

  • Indications: Gastroparesis, GERD, post-op ileus

  • Dose: 10 mg TDS, 30 minutes before meals

  • Side effects: EPS (10%), tardive dyskinesia, galactorrhea, QT prolongation

  • Black box warning: Risk of tardive dyskinesia with >3 months use

Domperidone:

  • Mechanism: Peripheral D2 antagonist (doesn't cross blood-brain barrier)

  • Indications: Gastroparesis, functional dyspepsia

  • Dose: 10 mg TDS before meals

  • Advantages: No EPS, safe in elderly

  • Side effects: Cardiac arrhythmias (high doses), hyperprolactinemia

Mosapride:

  • Mechanism: Selective 5-HT4 agonist

  • Indications: Functional dyspepsia, constipation-predominant IBS

  • Dose: 5 mg TDS

  • Advantages: No dopaminergic effects, minimal side effects

Prucalopride:

  • Mechanism: High-affinity 5-HT4 agonist

  • Indications: Chronic constipation in women

  • Dose: 2 mg OD

  • Advantages: Once-daily dosing, effective in severe cases

Prokinetic Selection Guide

Condition

First-line

Alternative

Avoid

Gastroparesis

Metoclopramide

Domperidone

Anticholinergics

Functional dyspepsia

Domperidone

Mosapride

High-dose metoclopramide

Chronic constipation

Prucalopride

Mosapride

Metoclopramide

Elderly patients

Domperidone

Mosapride

Metoclopramide

Mnemonic: "DMMP" for prokinetics → Domperidone (Doesn't cross BBB), Metoclopramide (Many side effects), Mosapride (Minimal problems), Prucalopride (Perfect for women)

High-Yield MCQ Mnemonics

These mnemonics target the exact pattern NEET PG uses to test GIT pharmacology:

PPI Mnemonic Masterclass

"OMEPRAZOLE PLANS":

  • Onset delayed (needs acid activation)

  • Mechanism: irreversible H+/K+-ATPase block

  • Effect lasts 24-72 hours

  • Peptric ulcer healing 90%

  • Rebound hyperacidity on stopping

  • Alkaline environment increases drug absorption

  • Zollinger-Ellison syndrome treatment

  • Osteoporosis risk (long-term)

  • Lead to B12 deficiency

  • Enhances clopidogrel metabolism (omeprazole specifically)

Pneumonia risk increased Low magnesium (hypomagnesemia) Acute interstitial nephritis Needs gastric acid for activation Safest PPI in pregnancy (omeprazole)

Antiemetic Mechanism Memory Tool

"DOVES FLY" for antiemetic targets:

  • D2 receptors → Metoclopramide, Domperidone

  • Ondansetron → 5-HT3 receptors

  • Vestibular → Scopolamine (muscarinic)

  • Emetic center → Promethazine (H1)

  • Serotonin → Ondansetron

First-line chemo → Ondansetron Levo-mepromazine → D2 + multiple receptors Yesterday's choice → Chlorpromazine (now second-line)

H. pylori Triple Therapy Memory Hook

"POLICEMAN ARRESTS CRIMINALS":

  • POliceman = PPI + Omega (twice daily)

  • ARRESTS = Amoxicillin Repeated doses

  • CRIMINALS = Clarithromycin

For resistance: "METRO POLICE":

  • METRO = Metronidazole replaces clarithromycin

  • POLICE = POliceman (PPI) + Levofloxacin + In Cases of Emerged resistance

Drug Interactions and Contraindications

Understanding GIT drug interactions prevents dangerous combinations and optimizes therapy.

Critical PPI Interactions

CYP2C19 substrates affected by omeprazole:

  • Clopidogrel: Reduced effectiveness → increased CV events

  • Warfarin: Increased levels → bleeding risk

  • Phenytoin: Increased levels → toxicity signs

Safe alternatives: Pantoprazole or rabeprazole have minimal CYP interactions.

Metoclopramide Contraindications

Absolute:

  • GI obstruction (increases motility against blockage)

  • Pheochromocytoma (can trigger hypertensive crisis)

  • Known tardive dyskinesia

  • Parkinson's disease (worsens symptoms)

Relative:

  • Age >65 years (increased EPS risk)

  • Renal failure (drug accumulation)

  • Cardiac arrhythmias (QT prolongation)

Antacid Spacing Requirements

Separate by 2 hours from:

  • Iron supplements (chelation reduces absorption)

  • Tetracyclines (chelation forms inactive complexes)

  • Fluoroquinolones (reduced bioavailability by 50-90%)

  • Ketoconazole (needs gastric acid for dissolution)



Clinical Application Scenarios


These scenarios mirror NEET PG question patterns:

Scenario 1: Post-operative Nausea

Patient: 45-year-old female, post-cholecystectomy, severe nausea and vomiting First-line: Ondansetron 4 mg IV Why: 5-HT3 antagonists are most effective for post-operative nausea Alternative: Promethazine if ondansetron contraindicated

Scenario 2: Diabetic Gastroparesis

Patient: 50-year-old diabetic male with early satiety, bloating, vomiting undigested food First-line: Metoclopramide 10 mg TDS before meals Monitoring: Watch for EPS, especially in elderly Alternative: Domperidone if EPS occurs

Scenario 3: H. pylori in High-Resistance Area

Patient: 40-year-old male with peptic ulcer, lives in area with 30% clarithromycin resistance First-line: Bismuth quadruple therapy (14 days) Components: Bismuth + Metronidazole + Tetracycline + PPI Success rate: 85-90% vs 70% with standard triple therapy

When working through complex clinical scenarios like these, practice questions focused on GIT pharmacology help identify the exact decision points NEET PG tests - like choosing bismuth quadruple over triple therapy based on local resistance patterns.

Side Effect Spotting for MCQs

NEET PG loves testing side effect recognition. Here are the high-yield patterns:

Classic PPI Side Effects (Long-term Use)

Scenario: "A 65-year-old patient on omeprazole for 3 years presents with..."

  • Bone fractures → Hip/spine/wrist (mechanism: reduced calcium absorption)

  • Megaloblastic anemia → B12 deficiency (mechanism: requires gastric acid for B12 release)

  • Tetany/seizures → Hypomagnesemia (mechanism: reduced Mg2+ absorption)

  • Pneumonia → Altered gastric pH allows bacterial overgrowth

Metoclopramide Toxicity Red Flags

Early signs: Restlessness, anxiety, facial spasms Late signs: Tardive dyskinesia (irreversible) High-risk groups: Elderly, prolonged use >3 months Treatment: Stop drug immediately, consider benztropine for acute EPS

Antacid Metabolic Effects

Aluminum hydroxide → Constipation, phosphate depletion Magnesium hydroxide → Diarrhea, hypermagnesemia (renal failure) Calcium carbonate → Rebound hyperacidity, milk-alkali syndrome Sodium bicarbonate → Metabolic alkalosis, fluid retention

Frequently Asked Questions

What's the difference between PPIs and H2 blockers for peptic ulcer healing?

PPIs achieve 90-95% acid suppression and heal 90% of duodenal ulcers in 4 weeks. H2 blockers achieve 70-80% suppression and heal 70% of ulcers in 6-8 weeks. PPIs are first-line because they provide faster, more complete healing with once-daily dosing.

When do you use domperidone over metoclopramide?

Use domperidone in elderly patients, those at risk for extrapyramidal side effects, or when long-term prokinetic therapy is needed. Domperidone doesn't cross the blood-brain barrier, so it causes minimal neurological side effects but maintains equal prokinetic efficacy.

How do you remember which antiemetic to use for chemotherapy vs motion sickness?

Think mechanism: Chemotherapy causes nausea via serotonin release from gut → use 5-HT3 antagonists (ondansetron). Motion sickness involves vestibular system → use anticholinergics (scopolamine) or antihistamines (promethazine).

Why has H. pylori triple therapy success rate declined?

Clarithromycin resistance has increased from <10% to 25-30% in India over the past decade. When resistance exceeds 15-20%, triple therapy success drops below 80%. This is why current guidelines recommend bismuth quadruple therapy as first-line in high-resistance areas.

What's the most important PPI drug interaction to remember?

Omeprazole inhibits CYP2C19, reducing clopidogrel's effectiveness and increasing warfarin levels. Use pantoprazole or rabeprazole in patients on these medications, as they have minimal CYP interactions.

When do PPIs cause rebound hyperacidity and how do you prevent it?

Rebound occurs after stopping long-term PPIs (>8 weeks) due to gastrin-induced parietal cell hyperplasia. Prevent by tapering over 4-8 weeks or switching to H2 blockers before discontinuation. The rebound typically resolves in 1-2 weeks after complete discontinuation.

Prepare smarter with Oncourse AI — adaptive MCQs, spaced repetition, and AI explanations built for NEET PG. Download free on Android and iOS